Home
About Us
Who Are We ?
Vision & Mission
Promoters
Manufacturing Sites
BLL (WHO-GMP)
------
Brooks Steriscience
Our Products
General Products
Liquid Injection Ampoules
Liquid Injection Vials
Dry Powder Injection Vials
Lyophilized Injections
Eye/Ear Drops
Nasal Drops
β-Lactam Range
Tablets
Dry Powder Syrup
Injection
Cephalosporin Range
Tablets
Dry Powder Syrup
Injection
Sales & Marketing
India
CCD
Institutional Business
CDMO Services
International
Our Global Presence
Investors
Investors Forum
Committee Details
Contact Us
Product Enquiry
Investor Enquiry
Career Enquiry
Policies
Details of Business
Disclaimer
Financial Results
Annual Report
Annual Return
MOA AOA
Preferential Allotment
List of Directors
Shareholding Pattern
Newspaper Advertisements
Policies
Notices
Voting Results
Disclosure Under Regulation-30
Secreterial Compliance Report
Annual Reports of Subsidiary Companies
Related Party Transaction
Investors Contact
Investor Forms
Right Issue
Prospectus
Credit Rating
Policies
Criteria for making payment to Non executive Directors
Familiarization Programme of Independent Directors
Policy on materiality of related party transactions
Vigil Mechanism Brooks
Policy for Determining Material Subsidiaries
Nomination and Remuneration Policy for Directors, Key Managerial Personnel and other Employees
Detail of Familiarization Programme of Independent Directors
CSR Policy
Performance Evaluation Policy
Policy Determination of Materiality of Events
Documents Retention Archival Policy
Code of conduct
Code of conduct
Appointment letter of independent directors
LOA Independent Director
Code of practices and procedures for fair disclosure
Code of Practices and Procedures for Fair Disclosure